Rafael Molina

HER-2/neu in node-negative breast cancer: prognostic significance of overexpression influenced by the presence of in situ carcinoma.

D. Craig Allred, Gary M. Clark, Amol Tandon et al. · Journal of Clinical Oncology · 1992 · 458 citations

Medicine, Oncology, Pathology +14

Overexpression of HER-2/neu and its relationship with other prognostic factors change during the progression of in situ to invasive breast cancer

D. Craig Allred, Gary M. Clark, Rafael Molina et al. · Human Pathology · 1992 · 410 citations

Medicine, Oncology, Pathology +12

Assessing therapeutic responses in Kras mutant cancers using genetically engineered mouse models

Mallika Singh, Anthony Lima, Rafael Molina et al. · Nature Biotechnology · 2010 · 215 citations

Life Sciences, Genetics, Oncology +12

C-erbB-2, CEA and CA 15.3 serum levels in the early diagnosis of recurrence of breast cancer patients.

Rafael Molina, Judith Jo, Xavier Filella et al. · PubMed · 1999 · 87 citations

Medicine, Oncology, Pathology +16

Anti‐VEGF antibody therapy does not promote metastasis in genetically engineered mouse tumour models

Mallika Singh, Suzana S. Couto, William F. Forrest et al. · The Journal of Pathology · 2012 · 71 citations

Medicine, Oncology, Pharmacology +17